These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19086016)

  • 1. Investigation of breast cancer using two-dimensional MRS.
    Thomas MA; Lipnick S; Velan SS; Liu X; Banakar S; Binesh N; Ramadan S; Ambrosio A; Raylman RR; Sayre J; DeBruhl N; Bassett L
    NMR Biomed; 2009 Jan; 22(1):77-91. PubMed ID: 19086016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton MRS of the breast in the clinical setting.
    Mountford C; Ramadan S; Stanwell P; Malycha P
    NMR Biomed; 2009 Jan; 22(1):54-64. PubMed ID: 19086012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
    Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
    Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution magic angle spinning MRS of breast cancer tissue.
    Sitter B; Sonnewald U; Spraul M; Fjösne HE; Gribbestad IS
    NMR Biomed; 2002 Aug; 15(5):327-37. PubMed ID: 12203224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
    Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
    NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study.
    Mahon MM; deSouza NM; Dina R; Soutter WP; McIndoe GA; Williams AD; Cox IJ
    NMR Biomed; 2004 May; 17(3):144-53. PubMed ID: 15137039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra.
    Tugnoli V; Schenetti L; Mucci A; Parenti F; Cagnoli R; Righi V; Trinchero A; Nocetti L; Toraci C; Mavilla L; Trentini G; Zunarelli E; Tosi MR
    Int J Mol Med; 2006 Nov; 18(5):859-69. PubMed ID: 17016616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possibilities for improved early breast cancer detection by Padé-optimized magnetic resonance spectroscopy.
    Belkić K; Belkić D
    Isr Med Assoc J; 2011 Apr; 13(4):236-43. PubMed ID: 21598814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas.
    Martínez-Bisbal MC; Martí-Bonmatí L; Piquer J; Revert A; Ferrer P; Llácer JL; Piotto M; Assemat O; Celda B
    NMR Biomed; 2004 Jun; 17(4):191-205. PubMed ID: 15229932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue.
    De Silva SS; Payne GS; Thomas V; Carter PG; Ind TE; deSouza NM
    NMR Biomed; 2009 Feb; 22(2):191-8. PubMed ID: 18833545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical alterations from normal mucosa to gastric cancer by ex vivo magnetic resonance spectroscopy.
    Calabrese C; Pisi A; Di Febo G; Liguori G; Filippini G; Cervellera M; Righi V; Lucchi P; Mucci A; Schenetti L; Tonini V; Tosi MR; Tugnoli V
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1386-95. PubMed ID: 18559553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
    Sitter B; Bathen TF; Singstad TE; Fjøsne HE; Lundgren S; Halgunset J; Gribbestad IS
    NMR Biomed; 2010 May; 23(4):424-31. PubMed ID: 20101607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy.
    Cheng LL; Chang IW; Smith BL; Gonzalez RG
    J Magn Reson; 1998 Nov; 135(1):194-202. PubMed ID: 9799694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton MR spectroscopy of the prostate.
    Mueller-Lisse UG; Scherr MK
    Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 31P MRSI and 1H MRS at 7 T: initial results in human breast cancer.
    Klomp DW; van de Bank BL; Raaijmakers A; Korteweg MA; Possanzini C; Boer VO; van de Berg CA; van de Bosch MA; Luijten PR
    NMR Biomed; 2011 Dec; 24(10):1337-42. PubMed ID: 21433156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in nuclear magnetic resonance spectroscopy for early cancer diagnosis].
    Gao XX; Xu YZ; Zhao MX; Qi J; Li HZ; Wu JG
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1942-50. PubMed ID: 18975839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
    Booth SJ; Pickles MD; Turnbull LW
    BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue.
    Gribbestad IS; Fjösne HE; Haugen OA; Nilsen G; Krane J; Petersen SB; Kvinnsland S
    Anticancer Res; 1993; 13(6A):1973-80. PubMed ID: 8297103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.